1.0
31. Mai 2014
Aktueller Mitarbeiter, mehr als 1 Jahr
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
The expense reporting recently was improved and now paid within a week. If you don't like senior management wait about 12 months. The CEO will put a new regime in to fix the declining product sales.
Kontras
CEO way too involved and very shrewd when it comes to giving any stock RSU/options or salary increases. CEO also couldn't tell you anything about how to sell the products company has. CEO likes to buy bottom feeder drugs no other company wants. They have no clue in how to sell and launch orphan drugs.